Multiplex Editing of OsMads26, OsBsr-d1, OsELF3-2 and OsERF922 with CRISPR/Cas9 Confers Enhanced Resistance to Pathogens and Abiotic Stresses and Boosts Grain Yield in Rice (Oryza sativa)
International Journal of Molecular Sciences · 13.01.2026 · 27 (2) · 781
DOI: 10.3390/ijms27020781 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.01.2026. Verfasst von Hailing Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Crop Genetic Improvement and Biotechnology Laboratory, Guangxi Academy of Agricultural Sciences, Nanning 530001, China. Hauptthemen laut MEDLINE: Oryza, CRISPR-Cas Systems, Disease Resistance, Plant Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of China, Central Government Guidance on Local Science and Technology Development Fund of Guangxi, Guangxi Natural Science Foundation.
Abstract (Originalsprache)
Rice (Oryza sativa) is one of the world’s major staple foods. However, stable rice production is constrained by various biotic and abiotic and stresses. Breeding and cultivation of rice varieties with resistance to multiple pathogens and environmental stresses is the most effective strategy to mitigate the adverse effect of pathogen attacks and abiotic stresses. Recently, researchers have focused on the exploitation of CRISPR/Cas9 technology to manipulate some negative defense-regulator genes to generate rice varieties with broad-spectrum resistance against rice pathogens. In this study, four negative regulator genes of rice blast, OsMads26, OsBsr-1, OsELF3-2 and OsERF922, were selected as CRISPR/Cas9 targets. By simultaneously knocking out all four genes via CRISPR/Cas9 technology, we created three mads26/bsr-1/elf3-2/erf922 quadruple knockout mutants. Our results demonstrated that all quadruple mutants exhibited much higher resistance not only to rice blast and bacterial blight but also to drought and salt stresses than the wildtype. Interestingly, grain yield of all three quadruple mutants was also drastically increased by 17.35% to 21.95%. Therefore, this study provides a novel strategy to rapidly improve rice varieties with broad-spectrum resistance to pathogens, elevated tolerance to abiotic stresses and enhanced yield potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Crop Genetic Improvement and Biotechnology Laboratory, Guangxi Academy of Agricultural Sciences, Nanning 530001, China.
ORCID-Profile: Ju Gao, Chonglie Ma
Förderung
- National Science Foundation of China
- Central Government Guidance on Local Science and Technology Development Fund of Guangxi
- Guangxi Natural Science Foundation
- Fund of Guangxi Academy of Agricultural Sciences for Basic Researches
Zitieren
APA
Luo, H., Zou, H., Lin, S., Liu, J., Zhou, G., Gao, L., Huang, J., Li, J., Gao, J., & Ma, C. (2026). Multiplex Editing of OsMads26, OsBsr-d1, OsELF3-2 and OsERF922 with CRISPR/Cas9 Confers Enhanced Resistance to Pathogens and Abiotic Stresses and Boosts Grain Yield in Rice (Oryza sativa). International Journal of Molecular Sciences, 27(2), 781. https://doi.org/10.3390/ijms27020781
Vancouver
Luo H, Zou H, Lin S, Liu J, Zhou G, Gao L, et al. Multiplex Editing of OsMads26, OsBsr-d1, OsELF3-2 and OsERF922 with CRISPR/Cas9 Confers Enhanced Resistance to Pathogens and Abiotic Stresses and Boosts Grain Yield in Rice (Oryza sativa). International Journal of Molecular Sciences. 2026;27(2):781. doi:10.3390/ijms27020781
BibTeX
@article{Luo2026,
author = {Luo, Hailing and Zou, Hengwei and Lin, Shengli and Liu, Jiali and Zhou, Geng and Gao, Lijun and Huang, Jieyi and Li, Jiaxuan and Gao, Ju and Ma, Chonglie},
title = {Multiplex Editing of OsMads26, OsBsr-d1, OsELF3-2 and OsERF922 with CRISPR/Cas9 Confers Enhanced Resistance to Pathogens and Abiotic Stresses and Boosts Grain Yield in Rice (Oryza sativa)},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {2},
pages = {781},
doi = {10.3390/ijms27020781}
}
EUVIMED